US Patent

US7618594 — Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)

Formulation · Assigned to Geno LLC · Expires 2026-10-17 · 0y remaining

Vulnerability score 60/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a nitric oxide delivery system that converts nitrogen dioxide to nitric oxide using a surface-active material and antioxidant.

USPTO Abstract

A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.

Drugs covered by this patent

Patent Metadata

Patent number
US7618594
Jurisdiction
US
Classification
Formulation
Expires
2026-10-17
Drug substance claim
No
Drug product claim
Yes
Assignee
Geno LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.